Disease Information |
Disease Name |
Gene Name |
Type |
UMLS |
Association Type |
Score |
Source |
Drug-Related Side Effects and Adverse Reactions |
ABCB1 |
group |
C0041755 |
Biomarker |
0.5 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
HSPB6 |
group |
C0041755 |
Therapeutic |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
ARID5B |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
HOMER1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
TLR2 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
NR3C1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
IL3 |
group |
C0041755 |
Therapeutic |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
SLC34A2 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
COMMD1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
C3 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
UGT1A1 |
group |
C0041755 |
Therapeutic |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
ORM1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
HP |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
ALB |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
AHSG |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
ABCC1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
PLK2 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
B2M |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
SLCO1B1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
CYP2C9 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
SHMT1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
HLA-B |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
REN |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
ACHE |
group |
C0041755 |
Therapeutic |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
GSTA1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
SPP1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
LCN2 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
CLU |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
NAT2 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
CES2 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
ABCC4 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
MTR |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
PPARA |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
ABCG2 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
CST3 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
CSF2 |
group |
C0041755 |
Therapeutic |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
MTRR |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
TOP1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
VKORC1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
ABCC2 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
MOCOS |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
NAT1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
PLG |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
AFM |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
SOD1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
EPHX2 |
group |
C0041755 |
Therapeutic |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
CACNA1H |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
FGA |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
KITLG |
group |
C0041755 |
Therapeutic |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
HPX |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
MTHFR |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
GC |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
CYP2D6 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
ADORA1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
HAVCR1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
TTR |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
CYP1A2 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
THBD |
group |
C0041755 |
Therapeutic |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
CSF3 |
group |
C0041755 |
Therapeutic |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
SLC19A1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
CYP2E1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
BCHE |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
SERPINA1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
DHFR |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
HTR2B |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
IGF1 |
group |
C0041755 |
Therapeutic |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
HLA-C |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
TLR1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
HMGB1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
ADORA2A |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
TYMS |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
TF |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
ABCC12 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
NFE2L2 |
group |
C0041755 |
Therapeutic |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
AMBP |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
PTGS2 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
CYP2C8 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
ATIC |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
CP |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
SLCO2A1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
EPHA7 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
IGFBP1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
HMOX1 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
TCN2 |
group |
C0041755 |
Biomarker |
0.3 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
TXN |
group |
C0041755 |
Therapeutic |
0.2 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
ASS1 |
group |
C0041755 |
Biomarker |
0.2 |
disgenet |
Drug-Related Side Effects and Adverse Reactions |
TP53 |
group |
C0041755 |
Biomarker |
0.2 |
disgenet |
click here to return to the previous page |